Purchase Order 75F40123P00205

Award Date 8/4/23
Potential Completion Date 8/9/25
Potential Value $210K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Calverton, MD 20705, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Food and Drug Administration (FDA) has awarded a firm-fixed-price purchase order to Digim Solution LLC, a minority-owned, for-profit Asian-Pacific American business, for image processing, modeling, and drug release simulation software under the AIDAN project. The $91,390.00 contract has a period of performance ending on September 29, 2025. Digim Solution LLC is a contractor that has received multiple awards from the Department of Health and Human Services, including the FDA and...
This is a task order awarded by the Food and Drug Administration (FDA) to Digim Solution LLC, a minority-owned small business, under an indefinite-delivery, indefinite-quantity (IDIQ) contract. The task order is for 3D microscopy, AI-based quantification, and modeling to support non-clinical evaluation and regulatory submissions for complex injectable and insertable drug products. The task order has a firm fixed price of $360,000.00 and a period of performance through March 9, 2026. Digim...
This federal contract award, valued at $496,171, was issued by the U.S. Food and Drug Administration (FDA) to Digital Medicine Society Inc., a non-profit organization based in Boston, Massachusetts. The contract is for expanding patient-generated health data training, which supports the FDA's Center for Devices and Radiological Health's (CDRH) need to enhance its capabilities in this area. The contract is structured as a Definitive Firm Fixed Price arrangement and does not have a set-aside...
This contract was awarded by the Department of Health and Human Services Food and Drug Administration (HHS FDA) to Digital Infuzion, Inc., a minority-owned, for-profit Subchapter S corporation that provides software and healthcare IT services. The contract, valued at $730,303.96, was awarded under a Broad Agency Announcement (BAA) entitled "Integrating EHR RWD for FDA Regulated Submission and Clinical Research." The contract is a Definitive Contract with a Cost Plus Fixed Fee pricing...
This is a $3,539,788.80 firm-fixed price definitive contract awarded by the U.S. Department of Health and Human Services Food and Drug Administration (FDA) to International Consulting Associates, Inc. (ICA), an SBA-certified 8(a) minority-owned small disadvantaged business. The contract is for the scale-up of an existing Medical Device Evaluation (MDE) Artificial Intelligence (AI) pilot to an operational tool. ICA has an extensive track record supporting federal health agencies like HHS and...
This firm fixed-price purchase order was awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to HK3 Lab S.R.L., a for-profit organization, to provide an Artificial Intelligence Technical Expert. The contract, which does not have a set-aside designation, has a potential value of $155,000.00 and a completion date of August 9, 2026. The contract was awarded on August 10, 2021 in response to a pre-solicitation opportunity posted on February 24, 2021 with a...
This is a federal contract award issued by the Food and Drug Administration (FDA), a civilian agency, to Diamond Solutions, Inc., a small disadvantaged business, for a delivery order valued at $5,966,016.58. The contract is a time and materials type contract with a period of performance through September 29, 2017. The contract has no set-aside designation. Based on the information provided, this award appears to be part of the FDA's regular program work, though the specific products or...
<p>This is a $359,880.23 firm fixed price definitive contract awarded by the Food and Drug Administration (FDA), a civilian agency, to US Data Management, LLC for a pilot project to support the implementation of the Drug Supply Chain Security Act. The contract does not have a set-aside designation. The contract's ultimate completion date is September 15, 2020. No other details about major subcontractors or the agency's broader programs are provided in the information given.</p>
This firm fixed-price delivery order was awarded by the Department of Health and Human Services Food and Drug Administration to Disys Solutions, Inc. (DSI) under the Solutions for Enterprise Wide Procurement V (SEWP V) government-wide acquisition contract (GWAC). The $20,328.00 award is for a new 5-year maintenance contract for five Fujitsu scanners, with a completion date of September 30, 2025. DSI is a Minority Owned, Subcontinent Asian (Asian-Indian) American Owned business that has...
The Food and Drug Administration (FDA) awarded a $4,812,979.00 Firm Fixed Price delivery order to Mpf-Zai Solutions LLC, a minority and woman-owned small business, to provide document control center support services for the FDA's Center for Drug Evaluation and Research (CDER). This award is part of a larger $112 million single-award Indefinite Delivery Vehicle (IDV) contract with the FDA, which was set aside for competitive 8(a) firms. Mpf-Zai Solutions has also received multiple task orders...

The U.S. Food and Drug Administration (FDA) has awarded a $210,000.00 firm fixed-price purchase order contract to Digim Solution LLC, a minority-owned, for-profit, Asian-Pacific American business located in Woburn, Massachusetts. The contract is for "ADVANCE PRODUCT CHARACTERIZATION AND ARTIFICIAL INTELLIGENCE ANALYSIS" and has an ultimate completion date of August 9, 2025.

This award is part of a larger $5,000,500.00 indefinite delivery vehicle (IDV) contract that Digim Solution LLC has with the FDA, spanning from June 20, 2024, to June 20, 2029. The IDV is specifically for 3D microscopy, artificial intelligence-based quantification, and modeling to support non-clinical evaluation and regulatory activities for complex drug products. Under this IDV, Digim Solution has already received a $360,000 task order for 3D microscopy and AI-based quantification to evaluate quality attributes and critical performance of complex injectable and insertable drug products. The contract does not have a set-aside designation.

Generated 5/4/25, 1:06 AM